These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
30. THE CHRYSANTHEMUM PHENOTYPE OF IDIOPATHIC MULTIFOCAL CHOROIDITIS. Ramtohul P, Cicinelli MV, Dolz-Marco R, Gal-Or O, Mrejen S, García-Martínez JR, Goldberg A, Cunha de Souza E, Miserocchi E, Cunningham ET, Yannuzzi LA, Freund KB, Tsui E. Retina; 2023 Aug 01; 43(8):1377-1385. PubMed ID: 37071923 [Abstract] [Full Text] [Related]
32. Serpiginous-like choroiditis as a marker for tuberculosis in a non-endemic area. Gan WL, Jones NP. Br J Ophthalmol; 2013 May 01; 97(5):644-7. PubMed ID: 23449344 [Abstract] [Full Text] [Related]
35. Efficacy and safety of conbercept as a primary treatment for choroidal neovascularization secondary to punctate inner choroidopathy. Peng Y, Zhang X, Mi L, Liu B, Zuo C, Li M, Wen F. BMC Ophthalmol; 2017 Jun 12; 17(1):87. PubMed ID: 28606070 [Abstract] [Full Text] [Related]
36. Deep inside Multifocal Choroiditis: an Optical Coherence Tomography Angiography approach. Cerquaglia A, Lupidi M, Fiore T, Iaccheri B, Perri P, Cagini C. Int Ophthalmol; 2017 Aug 12; 37(4):1047-1051. PubMed ID: 27590527 [Abstract] [Full Text] [Related]
37. Fundus autofluorescence in multifocal choroiditis and panuveitis. Haen SP, Spaide RF. Am J Ophthalmol; 2008 May 12; 145(5):847-53. PubMed ID: 18329623 [Abstract] [Full Text] [Related]
38. Risk Factors for Developing Choroidal Neovascular Membrane and Visual Loss in Punctate Inner Choroidopathy. Niederer RL, Gilbert R, Lightman SL, Tomkins-Netzer O. Ophthalmology; 2018 Feb 12; 125(2):288-294. PubMed ID: 28993011 [Abstract] [Full Text] [Related]